Abstract | UNLABELLED: Health benefits of Kochujang (KCJ) and its bioactive compounds have been reported in several in vitro and animal studies. OBJECTIVE: The aim of this study was to investigate the efficacy of KCJ supplementation on body composition and blood lipid profiles in overweight adults. METHODS: Sixty overweight men and women with BMI ≥23 kg/m2 and waist-hip-ratio (WHR) ≥0.90 for men and ≥0.85 for women were randomly assigned to a KCJ supplement ( n=30, 32 g/day) or placebo ( n=30, 32 g/day) group for a 12-week, double-blind, placebo controlled study. We measured anthropometric parameters, serum lipid profiles, abdominal fat distribution by computerized tomography and calculated the atherosclerosis indices in 53 subjects (n=26 in KCJ group, n=27 in placebo group) who completed the study. RESULTS: After 12 weeks, the KCJ group showed a significant reduction in visceral fat (cm2) (p<0.05), although body weight (kg) and WHR did not change. Serum concentration of triglycerides and ApoB were decreased when compared to those of the placebo group. CONCLUSION: KCJ supplementation (32 g/day) for 12 weeks in overweight adults showed anti-atherosclerotic and anti-obesogenic effects. TRIAL REGISTRATION: Clinical trials.gov Identifier: NCT01532375.
|
Authors | Youn-Soo Cha, Soo-Ran Kim, Ji-Ae Yang, Hyang-Im Back, Min-Gul Kim, Su-Jin Jung, Won O Song, Soo-Wan Chae |
Journal | Nutrition & metabolism
(Nutr Metab (Lond))
Vol. 10
Issue 1
Pg. 24
(Feb 26 2013)
ISSN: 1743-7075 [Print] England |
PMID | 23442518
(Publication Type: Journal Article)
|